UPDATE: Watchdog: EpiVacCorona test to start after mass production - Chemical Industry - PRIME Business News Agency - All News Politics Economy Business Wire Financial Wire Oil Gas Chemical Industry Power Industry Metals Mining Pulp Paper Agro Commodities Transport Automobile Construction Real Estate Telecommunications Engineering Hi-Tech Consumer Goods Retail Calendar Our Features Interviews Opinions Press Releases

UPDATE: Watchdog: EpiVacCorona test to start after mass production

(adds details in last 3 paragraphs)

MOSCOW, Oct 15 (PRIME) -- The post-registration trial of the coronavirus vaccine EpiVacCorona will start after mass production of the vaccine, an official of the Federal Service for Consumer Rights Protection and Human Welfare Oversight said on Thursday.

"The Novosibirsk center Vector will start a multi-center clinical trial with 40,000 volunteers after industrial volumes of the registered vaccine are produced," the statement read.

President Vladimir Putin said on Wednesday that Russia registered a second vaccine for the coronavirus produced by the Vector State Center for Virology and Biotechnology (Vector Institute).

Healthcare Minister Mikhail Murashko said that the vaccine has some advantages over Sputnik V.

“It is built on a different technology. It will give us an arsenal to produce the vaccines because the technological cycle is a bit easier," Murashko said.

He also said that the amount of coronavirus vaccine supplies is to rise in November–December.

End %%mk/jst%%

15.10.2020 13:30
Share |
To report an error select text and press Ctrl+Enter
Central Bank Official Rate
1W 1M 1Y
EUR 90.4629 +0.4338 28 nov
USD 75.8599 +0.4081 28 nov
Stock Market Indices
1D 1W 1M 1Y
rtsi 1224.65 -1.11 14:14 13 nov
micex 3014.25 -0.38 14:14 13 nov
Stock Quotes in RUR
1D 1W 1M 1Y
gazp 179.33 +3.71 13:59 13 nov
lkoh 4854.50 +0.03 13:59 13 nov
rosn 414.30 +0.49 13:59 13 nov
sber 241.46 -0.26 13:59 13 nov
MICEX Ruble Trading
1D 1W 1M 1Y
EURTD 91.6275 +0.5075 13:59 13 nov
USDTD 77.4900 +0.2550 13:59 13 nov